<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00743535</url>
  </required_header>
  <id_info>
    <org_study_id>03/2008</org_study_id>
    <nct_id>NCT00743535</nct_id>
  </id_info>
  <brief_title>Anterior Defect Correction With Mesh Plus Treatment of Stress Incontinence With Transobturator or Transvaginal Approach</brief_title>
  <official_title>A Comparison in Terms of Efficacy and Safety Between Transobturator and Transvaginal Tape Performed at the Same Time of Anterior Defect Correction With Mesh</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Magna Graecia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Magna Graecia</source>
  <brief_summary>
    <textblock>
      The incidence of anterior pelvic defect in women is estimated about 10% and it may be often
      associated to urinary stress incontinence. To date the correction of anterior defects with
      the use of graft material inserted with transobturator approach has become of large use.
      Moreover, given the frequent association of urinary stress incontinence to anterior defect,
      in most of cases it becomes necessary to perform at the same time an anti-incontinence
      procedure, i.e. a sub-urethral sling positioning. Based on these considerations the aim of
      this trial will be to compare two different approach for sub-urethral sling positioning,
      transobturator and transvaginal tape (TOT and TVT) performed in association to transobturator
      correction of anterior defect with mesh in terms of efficacy and safety.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women with anterior defect and genuine stress urinary incontinence will be enrolled and
      randomized in two groups (arm 1 and 2). All patients will be treated with a transobturator
      correction of anterior defect, in patients of arm 1 will be associated TOT, whereas in
      patients of arm 2 will be associated TVT.

      All patients eligible will undergo baseline assessment consisting of anthropometric,
      clinical, hormonal, urodynamic, and ultrasonographic evaluations. During the study, the
      surgical outcomes, the clinical subjective and objective efficacy data, and the adverse
      experiences will be evaluated in each patient.

      Data will be analyzed using the intention-to-treat principle and a P value of 0.05 or less
      will be considered significant.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low recruitment rate.
  </why_stopped>
  <start_date>February 2008</start_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Objective/subjective symptoms improvements</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-operative complication rate</measure>
    <time_frame>one day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Failure rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence rate</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual function</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Cystocele</condition>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transobturatory correction of anterior defect plus TOT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Longitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage.
Small incision sites at sovrapubic level. Bilateral retropubic insertion of mesh by means of mono-use needle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transobturatory correction of anterior defect plus TOT</intervention_name>
    <description>Longitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage.
Small incision sites in the femoral/pelvic fold. Bilateral transobturator insertion of mesh by means of mono-use needle</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transobturatory correction of anterior defect plus TVT</intervention_name>
    <description>Longitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage.
Small incision sites at sovrapubic level. Bilateral retropubic insertion of mesh by means of mono-use needle.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cystocele

          -  Genuine stress urinary incontinence by self report, examination and test

          -  Urethral hypermobility

          -  Eligible for both surgical procedures

          -  Ambulatory

        Exclusion Criteria:

          -  Pregnancy

          -  &lt;12 months post-partum

          -  Systemic disease and/or drugs known to affect bladder function

          -  Current chemotherapy or radiation therapy

          -  Urethral diverticulum, augmentation cytoplasty, or artificial sphincter

          -  Recent pelvic surgery

          -  Previous pelvic or anti-incontinence surgery

          -  History of severe abdominopelvic infections

          -  Known extensive abdominopelvic adhesions

          -  Detrusor instability and/or intrinsic sphincter dysfunction

          -  Other gynaecologic pathologies (eg, fibroids, ovarian cysts)

          -  BMI &gt;30
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefano Palomba, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chair of Obstetrics and Gynecology, University &quot;Magna Graecia&quot; of Catanzaro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fulvio Zullo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Chair of Obstetrics and Gynecology, University &quot;Magna Graecia&quot; of Catanzaro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>&quot;Pugliese&quot; Hospital</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2008</study_first_submitted>
  <study_first_submitted_qc>August 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2008</study_first_posted>
  <last_update_submitted>April 5, 2013</last_update_submitted>
  <last_update_submitted_qc>April 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Magna Graecia</investigator_affiliation>
    <investigator_full_name>Stefano Palomba</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Cystocele</keyword>
  <keyword>Mesh</keyword>
  <keyword>Prolapse</keyword>
  <keyword>Sling</keyword>
  <keyword>Stress incontinence</keyword>
  <keyword>Surgery</keyword>
  <keyword>TOT</keyword>
  <keyword>TVT</keyword>
  <keyword>Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
    <mesh_term>Cystocele</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

